January 13, 2012 (New York, New York) — As the controversy over the research fraud allegations against Dr Dipak Das enter its third day, researchers, clinicians, and red-wine enthusiasts more generally are wondering just what the news means for the field of resveratrol research. At the very least, scientists told heartwire, plans for an international meeting scheduled for later this year have been turned upside down: Das was one of just eight international experts on the scientific committee for Resveratrol 2012.
As previously reported by heartwire, the University of Connecticut found evidence that Das had fabricated and falsified data in dozens of published papers, many asserting that resveratrol, found in red wine, improved cardiovascular health. The university is in the process of dismissing Das and has already returned $890 000 of the federal research funding awarded to Das.
Artículo completo aquí: http://www.medscape.com/viewarticle/756905